{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:25:01Z","timestamp":1794223501206,"version":"4.8.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Bladder cancer (BCa) is the most common genitourinary malignancy and causes substantial economic losses worldwide. Recent studies suggest overexpression of\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      in BCa, but its mechanistic contributions to carcinogenesis and ferroptosis regulation remain unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      From August 2021 to January 2024, 98 pairs of BCa and adjacent normal tissue samples were collected from the Third Xiangya Hospital, Central South University. Gene\/protein expression, lipid reactive oxygen species (ROS) levels, and cell viability were analyzed. Interactions among\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      \/YTH domain-containing protein 1 (YTHDC1), circCD2AP, insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3), and IGF2BP3\/forkhead box C1 (FOXC1) were validated, along with\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      -IGF2BP3 colocalization. FOXC1 binding sites in the Parkinson\u2019s disease protein 7 (PARK7) promoter were mapped. N6-methyladenosine (m6A) modifications on\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      were quantified via methylated RNA immunoprecipitation polymerase chain reaction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      circCD2AP was significantly upregulated in BCa and positively correlated with PARK7 expression (\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0.1357,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0002). Patients with high\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      expression showed poorer survival rates.\n                      <jats:italic toggle=\"yes\">CircCD2AP<\/jats:italic>\n                      knockdown sensitized BCa cells to ferroptosis inducers (erastin and Ras-selective lethal small molecule 3). Methyltransferase-like 3 (\n                      <jats:italic toggle=\"yes\">METTL3<\/jats:italic>\n                      ) knockdown inhibited\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      m6A modification and relative expression. YTHDC1 mediated m6A-dependent cytoplasmic export of circCD2AP (2.8-fold increase). Besides,\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      stabilized\n                      <jats:italic toggle=\"yes\">FOXC1<\/jats:italic>\n                      messenger RNA (mRNA), and FOXC1 bound the\n                      <jats:italic toggle=\"yes\">PARK7<\/jats:italic>\n                      promoter to enhance its expression. Knockdown of\n                      <jats:italic toggle=\"yes\">FOXC1<\/jats:italic>\n                      or\n                      <jats:italic toggle=\"yes\">PARK7<\/jats:italic>\n                      blocked the antiferroptotic effect of\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      overexpression in BCa cells. Knockdown of\n                      <jats:italic toggle=\"yes\">METTL3<\/jats:italic>\n                      or\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      reduced tumor burden in mice, decreasing both volume (approximately 48.3% or 56.4%) and weight (approximately 65.3% or 58.7%) through FOXC1\/PARK7-mediated ferroptosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      METTL3-mediated m6A modification drives\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      overexpression, which is subsequently exported to the cytoplasm with enhanced efficiency mediated by YTHDC1. Cytoplasmic\n                      <jats:italic toggle=\"yes\">circCD2AP<\/jats:italic>\n                      stabilizes\n                      <jats:italic toggle=\"yes\">FOXC1<\/jats:italic>\n                      mRNA, enabling FOXC1-dependent transcriptional activation of\n                      <jats:italic toggle=\"yes\">PARK7<\/jats:italic>\n                      . This axis suppresses ferroptosis and promotes BCa progression, revealing a novel therapeutic target.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003744","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T12:01:40Z","timestamp":1758110500000},"page":"2621-2634","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["m6A-modified circCD2AP suppressed ferroptosis in bladder cancer by upregulating FOXC1 to promote PARK7 transcriptional activity"],"prefix":"10.1097","volume":"139","author":[{"given":"Jinrong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan,410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan,410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan,410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan,410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan,410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan,410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"R1-20261109","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality Worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20261109","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/CM9.0000000000002512","article-title":"Comparison of the survival outcomes between primary and secondary muscle-invasive bladder cancer: A propensity score-matched study","volume":"136","author":"Lok","year":"2023","journal-title":"Chin Med J"},{"key":"R3-20261109","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41571-018-0026-y","article-title":"Treatment resistance in urothelial carcinoma: An evolutionary perspective","volume":"15","author":"Vlachostergios","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R4-20261109","article-title":"Novel combination therapies for the treatment of bladder cancer","volume":"10","author":"Peng","year":"2020","journal-title":"Front Oncol"},{"key":"R5-20261109","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12894-016-0122-1","article-title":"Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Gu\u00e9rin","volume":"16","author":"Fukumoto","year":"2016","journal-title":"BMC Urol"},{"key":"R6-20261109","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat Rev Genet"},{"key":"R7-20261109","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jcp.30608","article-title":"Regulation of cancer progression by circRNA and functional proteins","volume":"237","author":"Chen","year":"2022","journal-title":"J Cell Physiol"},{"key":"R8-20261109","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12943-019-1040-0","article-title":"Circular RNA circSLC8A1 acts as a sponge of miR-130b\/miR-494 in suppressing bladder cancer progression via regulating PTEN","volume":"18","author":"Lu","year":"2019","journal-title":"Mol Cancer"},{"key":"R9-20261109","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.canlet.2017.06.027","article-title":"Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA\/VEGFR2 signaling pathway","volume":"403","author":"Zhong","year":"2017","journal-title":"Cancer Lett"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4149\/neo_2019_190107N25","article-title":"Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer","volume":"66","author":"Liu","year":"2019","journal-title":"Neoplasma"},{"key":"R11-20261109","article-title":"The emerging role of m6a modification in regulating the immune system and autoimmune diseases","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R12-20261109","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41419-020-03071-y","article-title":"N(6)-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1\/HK2 modification","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"R13-20261109","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41388-019-0683-z","article-title":"The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-\u03baB\/MYC signaling network","volume":"38","author":"Cheng","year":"2019","journal-title":"Oncogene"},{"key":"R14-20261109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tcb.2017.10.001","article-title":"Reading m(6)A in the transcriptome: m(6)A-binding proteins","volume":"28","author":"Patil","year":"2018","journal-title":"Trends Cell Biol"},{"key":"R15-20261109","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107641","article-title":"Modulation of circRNA metabolism by m(6)A modification","volume":"31","author":"Di Timoteo","year":"2020","journal-title":"Cell Rep"},{"key":"R16-20261109","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41467-019-12651-2","article-title":"N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis","volume":"10","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"key":"R17-20261109","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.7150\/thno.42174","article-title":"Circular RNA-protein interactions: Functions, mechanisms, and identification","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"13949","DOI":"10.1111\/jcmm.16003","article-title":"IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK\/STAT signalling pathway in human bladder cancer","volume":"24","author":"Huang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R19-20261109","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1512","article-title":"circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma","volume":"13","author":"Liu","year":"2023","journal-title":"Clin Transl Med"},{"key":"R20-20261109","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41417-022-00526-6","article-title":"m(6)A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis","volume":"30","author":"Cui","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"R21-20261109","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.18632\/oncotarget.22742","article-title":"FOXC1, the new player in the cancer sandbox","volume":"9","author":"Elian","year":"2018","journal-title":"Oncotarget"},{"key":"R22-20261109","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/hep.26029","article-title":"Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma","volume":"57","author":"Xia","year":"2013","journal-title":"Hepatology"},{"key":"R23-20261109","article-title":"Exosome-mediated mir-4792 transfer promotes bladder cancer cell proliferation via enhanced FOXC1\/c-Myc signaling and warburg effect","volume":"2022","author":"Wu","year":"2022","journal-title":"J Oncol"},{"key":"R24-20261109","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s10020-021-00271-w","article-title":"ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia\/reperfusion injury by regulating autophagy","volume":"27","author":"Chen","year":"2021","journal-title":"Mol Med"},{"key":"R25-20261109","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"R26-20261109","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: Process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ"},{"key":"R27-20261109","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41467-020-15109-y","article-title":"DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase","volume":"11","author":"Cao","year":"2020","journal-title":"Nat Commun"},{"key":"R28-20261109","article-title":"Correction to virus bioresistor (VBR) for the detection of the bladder cancer marker DJ-1 in urine at 10 pM in one minute","volume":"92","author":"Bhasin","year":"2020","journal-title":"Anal Chem"},{"key":"R29-20261109","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"R30-20261109","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.neo.2017.10.005","article-title":"Cysteine dioxygenase 1 mediates erastin-induced ferroptosis in human gastric cancer cells","volume":"19","author":"Hao","year":"2017","journal-title":"Neoplasia"},{"key":"R31-20261109","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1100\/2011\/251920","article-title":"Bladder cancer","volume":"11","author":"Kader","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"R32-20261109","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/medicina57080749","article-title":"Bladder cancer: Current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R33-20261109","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: Characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"R34-20261109","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"R35-20261109","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/imr.12533","article-title":"Ferroptosis: Bug or feature","volume":"277","author":"Dixon","year":"2017","journal-title":"Immunol Rev"},{"key":"R36-20261109","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.7150\/ijbs.66917","article-title":"Ferroptosis in cancer progression: Role of noncoding RNAs","volume":"18","author":"Zuo","year":"2022","journal-title":"Int J Biol Sci"},{"key":"R37-20261109","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/cbin.11444","article-title":"CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p\/GPX4 axis","volume":"44","author":"Xu","year":"2020","journal-title":"Cell Biol Int"},{"key":"R38-20261109","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41374-022-00826-3","article-title":"CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1\/P38 axis","volume":"102","author":"Wang","year":"2022","journal-title":"Lab Invest"},{"key":"R39-20261109","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"key":"R40-20261109","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102151","article-title":"N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells","volume":"47","author":"Shen","year":"2021","journal-title":"Redox Biol"},{"key":"R41-20261109","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10565-021-09660-7","article-title":"METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis","volume":"39","author":"Zhuang","year":"2023","journal-title":"Cell Biol Toxicol"},{"key":"R42-20261109","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","article-title":"METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner","volume":"18","author":"Han","year":"2019","journal-title":"Mol Cancer"},{"key":"R43-20261109","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119399","article-title":"Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis","volume":"276","author":"Song","year":"2021","journal-title":"Life Sci"},{"key":"R44-20261109","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12935-021-02433-6","article-title":"METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)A modification","volume":"22","author":"Xu","year":"2022","journal-title":"Cancer Cell Int"},{"key":"R45-20261109","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31311","article-title":"YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"Elife"},{"key":"R46-20261109","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12943-022-01497-w","article-title":"CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3","volume":"21","author":"Yang","year":"2022","journal-title":"Mol Cancer"},{"key":"R47-20261109","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"R48-20261109","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jnr.24356","article-title":"The interaction of circRNAs and RNA binding proteins: An important part of circRNA maintenance and function","volume":"98","author":"Zang","year":"2020","journal-title":"J Neurosci Res"},{"key":"R49-20261109","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13046-021-01829-6","article-title":"FOXC1 promotes HCC proliferation and metastasis by upregulating DNMT3B to induce DNA hypermethylation of CTH promoter","volume":"40","author":"Lin","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R50-20261109","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1007\/s10620-021-07226-5","article-title":"Overexpression of FOXC1 promotes tumor metastasis by activating the Wnt\/\u03b2-catenin signaling pathway in gastric cancer","volume":"67","author":"Sun","year":"2022","journal-title":"Dig Dis Sci"},{"key":"R51-20261109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1751-2980.2011.00488.x","article-title":"Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer","volume":"12","author":"He","year":"2011","journal-title":"J Dig Dis"},{"key":"R52-20261109","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41598-022-07065-y","article-title":"DJ-1 upregulates the Nrf2\/GPX4 signal pathway to inhibit trophoblast ferroptosis in the pathogenesis of preeclampsia","volume":"12","author":"Liao","year":"2022","journal-title":"Sci Rep"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:02:10Z","timestamp":1794222130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":52,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003744","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"2024-11-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}